Parathyroid hormone-related protein upregulates interleukin-1β-induced nitric oxide synthesis

Hypertension

Volumn 30, Issue 4, 1997, Pages 922-927

  Jiang, Bingbing ^b   Morimoto, Shigeto ^a   Yang, Jin ^b   Fukuo, Keisuke ^b   Hirotani, Atsushi ^b   Kitano, Shoichi ^b   Ogihara, Toshio ^b  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NONE

Author keywords

Interleukin 1; Muscle, smooth, vascular; Nitric oxide; Parathyroid hormones; Rats; RNA, messenger

Indexed keywords

INTERLEUKIN 1BETA; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PARATHYROID HORMONE RELATED PROTEIN;

ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; COMPETITIVE INHIBITION; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME REGULATION; HORMONE ACTION; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; VASCULAR SMOOTH MUSCLE;

EID: 0030777364     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.4.922     Document Type: Article

References (38)

1. Martin TJ, Moseley JM, Gillespie MT. Parathyroid hormone-related protein: biochemistry and molecular biology. Crit Rev Biochem Mol Biol. 1991;26:377-395.
2. Hongo T, Kupfer J, Enomoto H, Sharifi B, Giannella-Neto D, Forrester JS, Singer FR, Goltzman D, Hendy GN, Pirola C, Fagin JA, Clemens TL. Abundant expression of parathyroid hormone-related protein in primary rat aortic smooth muscle cells accompanies serum-induced proliferation. J Clin Invest. 1991;88: 1841-1847.
3. Rian E, Jemtland R, Olstad OK, Endresen MJ, Grasser WA, Thiede MA, Henriksen T, Bucht E, Gautvik KM. Parathyroid hormone-related protein is produced by cultured endothelial cells: a possible role in angiogenesis. Biochem Biophys Res Commun. 1994;198:740-747.
4. Nickols GA, Nana AD, Nickols MA, DiPette DJ, Asimakis GK. Hypotension and cardiac stimulation due to the parathyroid hormone-related protein, humoral hypercalcemia of malignancy factor. Endocrinology. 1989;125:834-841.
5. Roca-Cusachs A, DiPette DJ, Nickols GA. Regional and systemic hemodynamic effects of parathyroid hormone-related protein: preservation of cardiac function and coronary and renal flow with reduced blood pressure. J Pharmacol Exp Ther. 1991;256:110-118.
6. Musso MJ, Plante M, Judes C, Barthelmebs M, Helwig JJ. Renal vasodilatation and microvessel adenylate cyclase stimulation by synthetic parathyroid hormone-like protein fragments. Eur J Pharmacol. 1989;174:139-151.
7. Jiang BB, Morimoto S, Fukuo K, Yasuda O, Chen SY, Ogihara T. Role of parathyroid hormone-related protein in the proliferation of vascular smooth muscle cells. Miner Electrolyte Metab. 1995;21: 157-160.
8. Jiang BB, Morimoto S, Fukuo S, Hirotani A, Tamatani M, Nakahashi T, Nishibe A, Niinobu T, Hata S, Chen SY, Ogihara T. Parathyroid hormone-related protein inhibits endothelin-1 production. Hypertension. 1996;27[pt 1]:360-363.
9. Nakayama T, Ohtsuru A, Enomoto H, Namba H, Ozeki S, Shibata Y, Yokota T, Nobuyoshi M, Ito M, Sekine I, Yamashita T. Coronary atherosclerotic smooth muscle cells overexpress human parathyroid hormone-related peptides. Biochem Biophys Res Commun. 1994;200:1028-1035.
10. Ozeki S, Ohtsuru A, Seto S, Takeshita S, Yano H, Nakayama T, Ito M, Yokota T, Nobuyoshi M, Segre GV, Yamashita S, Yano K. Evidence that implicates the parathyroid hormone-related peptide in vascular stenosis. Arterioscler Thromb Vasc Biol. 1996;16:565-575.
11. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109-142.
12. Palmer RM, Bridge L, Foxwell NA, Moncada S. The role of nitric oxide in endothelial cell damage and its inhibition by glucocorticoids. Br J Pharmacol. 1992;105:11-12.
13. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 1992;6:3051-3064.
14. Zhang J, Dawson VL, Dawson TM, Snyder SH. Nitric oxide activation of poly (ADP-ribose) synthetase in neurotoxicity. Science. 1994;263:687-689.
15. Pinsky DJ, Cai B, Yang X, Rodriguez C, Sciacca RR, Cannon PJ. The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor beta. J Clin Invest. 1995;95:677-685.
16. Fukuo K, Inoue T, Morimoto S, Nakahashi T, Yasuda O, Kitano S, Sasada R, Ogihara T. Nitric oxide mediates cytotoxicity and basic fibroblast growth factor release in cultured vascular smooth muscle cells. J Clin Invest. 1995;95:669-676.
17. Fukuo K, Hata S, Suhara T, Nakahashi T, Shinto Y, Tsujimoto Y, Morimoto S, Ogihara T. Nitric oxide induces upregulation of Fas and apoptosis in vascular smooth muscle. Hypertension. 1996;27[pt 2]:823-826.
18. Tedgui A, Bernard C. Cytokines, immuno-inflammatory response and atherosclerosis. Eur Cytokine Netw. 1994;5:263-270.
19. Beasley D, Schwartz JH, Brenner BM. Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J Clin Invest. 1991;87:602-608.
20. Verbeuren TJ, Bonhomme E, Laubie M, Simonet S. Evidence for induction of nonendothelial NO synthase in aortas of cholesterol-fed rabbits. J Cardiovasc Pharmacol. 1993;21:841-845.
21. Joly GA, Schini VB, Vanhoutte PM. Balloon injury induces nitric oxide synthase activity in rat carotid arteries. J Cardiovasc Pharmacol. 1992;20:S151-S154.
22. Nakayama DK, Geller DA, DiSilvio M, Bloomgarden G, Davies P, Pitt BR, Hatakeyama K, Kagamiyama H, Simmons RL, Billiar TR. Tetrahydrobiopterin synthesis and inducible nitric oxide production in pulmonary artery smooth muscle. Am J Physiol. 1994;266: L455-L460.
23. Koh E, Morimoto S, Tomita J, Rakugi H, Jiang B, Inoue T, Nabata T, Fukuo K, Ogihara T. Effects of an angiotensin II receptor antagonist, CV-11974, on angiotensin II-induced increases in cytosolic free calcium concentration, hyperplasia, and hypertrophy of cultured vascular smooth muscle cells. J Cardiovasc Pharmacol. 1994;23:175-179.
24. Inoue T, Fukuo K, Morimoto S, Koh E, Ogihara T. Nitric oxide mediates interleukin-1-induced prostaglandin E2 production by vascular smooth muscle cells. Biochern Biophys Res Commun. 1993; 194:420-424.
25. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurements with the folin phenol reagent. J Biol Chem. 1951;193: 265-275.
26. Inoue T, Fukuo K, Nakahashi T, Hata S, Morimoto S, Ogihara T. cGMP upregulates nitric oxide synthase expression in vascular smooth muscle cells. Hypertension. 1995;25[pt 2]:711-714.
27. Busse R, Mulsch A. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett. 1990;275:87-90.
28. Kunz D, Muhl H, Walker G, Pfeilschifter J. Two distinct signaling pathways trigger the expression of inducible nitric oxide synthase in rat renal mesangial cells. Proc Natl Acad Sci U S A. 1994;91: 5387-5391.
29. Schini-Kerth VB, Fisslthaler B, Busse R. cGRP enhances induction of NO synthase in vascular smooth muscle cells via a cAMP-dependent mechanism. Am J Physiol. 1994;267:H2483-2490.
30. Oddis CV, Simmons RL, Hattler BG, Finkel MS. cAMP enhances inducible nitric oxide synthase mRNA stability in cardiac myocytes. Am J Physiol. 1995;269:H2044-H2050.
31. Scott-Burden T, Elizondo E, Ge T, Boulanger CM, Vanhoutte PM. Simultaneous activation of adenylyl cyclase and protein kinase C induces production of nitric oxide by vascular smooth muscle cells. Mol Pharmacol. 1994;46:274-282.
32. Alheid U, Frolich JC, Forstermann U. Endothelium-derived relaxing factor from cultured human endothelial cells inhibits aggregation of human platelets. Thromb Res. 1987;47:561-571.
33. Radomski MW, Palmer RM, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet. 1987;2:1057-1058.
34. Kubes P, Suzuki M, Granger DN. Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A. 1991; 88:4651-4655.
35. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83:1774-1777.
36. Nathan C, Xie QW. Nitric oxide synthases: roles, tolls, and controls. Cell. 1994;78:915-918.
37. Raines EW, Dower SK, Ross R. Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science. 1989;243:393-396.
38. Libby P, Warner SJ, Friedman GB. Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J Clin Invest. 1988;81:487-498.